Michel Ségui

566 total citations
8 papers, 499 citations indexed

About

Michel Ségui is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michel Ségui has authored 8 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michel Ségui's work include Cannabis and Cannabinoid Research (4 papers), Neuropeptides and Animal Physiology (2 papers) and Sleep and Wakefulness Research (2 papers). Michel Ségui is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Neuropeptides and Animal Physiology (2 papers) and Sleep and Wakefulness Research (2 papers). Michel Ségui collaborates with scholars based in France and Poland. Michel Ségui's co-authors include Jean‐Marie Derocq, Pierre Casellas, J Marchand, G. Le Fur, Monsif Bouaboula, Omar Jbilo, Gérard Le Fur, M Rinaldi-Carmona, B. Bourrié and Daniel Caput and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michel Ségui

8 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Ségui France 7 338 191 104 97 75 8 499
Murielle L. Rinaldi France 7 286 0.8× 168 0.9× 69 0.7× 200 2.1× 45 0.6× 9 537
B. Bourrié France 8 424 1.3× 334 1.7× 91 0.9× 247 2.5× 199 2.7× 11 779
Susan L. Gottshall United States 10 387 1.1× 330 1.7× 50 0.5× 185 1.9× 69 0.9× 12 810
Florence Pecceu France 7 403 1.2× 548 2.9× 83 0.8× 355 3.7× 81 1.1× 10 817
Yoshifumi Ueda Japan 9 254 0.8× 136 0.7× 32 0.3× 85 0.9× 47 0.6× 10 403
Sarah Bevan United Kingdom 9 300 0.9× 257 1.3× 93 0.9× 116 1.2× 14 0.2× 12 537
Belén Palomares Spain 13 317 0.9× 136 0.7× 35 0.3× 157 1.6× 57 0.8× 14 521
Romelda Omeir United States 9 485 1.4× 190 1.0× 34 0.3× 97 1.0× 15 0.2× 12 581
Alison Ribeiro Brazil 12 267 0.8× 45 0.2× 46 0.4× 171 1.8× 62 0.8× 20 536
Emanuela Talamonti Italy 11 222 0.7× 74 0.4× 23 0.2× 103 1.1× 71 0.9× 13 438

Countries citing papers authored by Michel Ségui

Since Specialization
Citations

This map shows the geographic impact of Michel Ségui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Ségui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Ségui more than expected).

Fields of papers citing papers by Michel Ségui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Ségui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Ségui. The network helps show where Michel Ségui may publish in the future.

Co-authorship network of co-authors of Michel Ségui

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Ségui. A scholar is included among the top collaborators of Michel Ségui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Ségui. Michel Ségui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Ségui, Michel, et al.. (2002). Revelado de manchas latentes: efectividad del luminol y evaluación de su efecto sobre el estudio del DNA. Cuadernos de Medicina Forense. 3 indexed citations
2.
Derocq, Jean‐Marie, et al.. (2000). Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60. Journal of Biological Chemistry. 275(21). 15621–15628. 86 indexed citations
3.
Jbilo, Omar, Jean‐Marie Derocq, Michel Ségui, Gérard Le Fur, & Pierre Casellas. (1999). Stimulation of peripheral cannabinoid receptor CB2 induces MCP‐1 and IL‐8 gene expression in human promyelocytic cell line HL60. FEBS Letters. 448(2-3). 273–277. 50 indexed citations
4.
Derocq, Jean‐Marie, Monsif Bouaboula, J Marchand, et al.. (1998). The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor‐independent pathway in hematopoietic cell lines. FEBS Letters. 425(3). 419–425. 69 indexed citations
6.
Derocq, Jean‐Marie, Michel Ségui, J Marchand, G. Le Fur, & Pierre Casellas. (1995). Cannabinoids enhance human B‐cell growth at low nanomolar concentrations. FEBS Letters. 369(2-3). 177–182. 151 indexed citations
7.
Derocq, Jean‐Marie, B. Bourrié, Michel Ségui, G. Le Fur, & Pierre Casellas. (1995). In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 224–230. 46 indexed citations
8.
Derocq, Jean‐Marie, Michel Ségui, A Minty, et al.. (1994). Interleukin‐13 stimulates interleukin‐6 production by human keratinocytes. FEBS Letters. 343(1). 32–36. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026